[{"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128-001", "question": "A 3-week-old male infant presents with progressive jaundice, acholic stools, and hepatomegaly. Laboratory studies reveal total bilirubin 12.4 mg/dL (direct 9.8 mg/dL), GGT 890 U/L, and ALT 156 U/L. Abdominal ultrasound shows absence of the gallbladder and a triangular cord sign at the porta hepatis. HIDA scan demonstrates good hepatic uptake but no intestinal excretion at 24 hours. Intraoperative cholangiogram confirms biliary atresia. The Kasai portoenterostomy is performed at 28 days of life. Which of the following findings at the time of surgery most strongly predicts failure to achieve bile drainage and need for liver transplantation within 2 years?", "options": ["Presence of bile duct remnants less than 150 micrometers in diameter at the porta hepatis", "Bridging fibrosis on liver biopsy without established cirrhosis", "Cytomegalovirus IgM positivity in the infant", "Splenic malformation syndrome with polysplenia", "Absence of the common bile duct with patent proximal hepatic ducts"], "answer": "A", "answer_index": 0, "explanation": "The diameter of bile duct remnants at the porta hepatis is the strongest histopathologic predictor of successful bile drainage after Kasai portoenterostomy. Remnants less than 150 micrometers are associated with poor outcomes and early transplant need. Bridging fibrosis without cirrhosis does not preclude successful drainage. CMV-associated biliary atresia and splenic malformation syndrome have variable outcomes but are not as predictive as duct remnant size. Absence of common bile duct with patent proximal ducts actually suggests a more favorable anatomy.", "generator_model": "claude-opus-4-5-20251101", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: V. Verdict: Correct best answer. The question asks for the strongest predictor of Kasai failure/transplant need within 2 years. Key stem clues: 3-week-old with biliary atresia confirmed by imaging and intraoperative cholangiogram, Kasai performed at 28 days. The question specifically asks about intraoperative findings predicting poor outcomes. Choice A (bile duct remnants <150 micrometers) is the established strongest histopathologic predictor of Kasai failure in the literature. This microscopic finding at the porta hepatis directly correlates with bile drainage success. Choice B (bridging fibrosis without cirrhosis) indicates advanced disease but is less predictive than duct remnant size. Choice C (CMV IgM) may worsen prognosis but is not the strongest predictor. Choice D (splenic malformation/polysplenia) represents biliary atresia splenic malformation syndrome with variable outcomes. Choice E (absent CBD with patent proximal ducts) actually suggests better anatomy for drainage, making it incorrect. The item is medically accurate, citing the well-established <150 micrometer threshold as the critical prognostic factor. All options are discriminable, and the keyed answer is uniquely defensible. Minimal fix: None needed; item is valid and accurate.\", \"medical_accuracy_score\": \"5\", \"logical_validity\": true, \"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best answer. The question asks for the strongest predictor of Kasai failure/transplant need within 2 years. Key stem clues: 3-week-old with biliary atresia confirmed by imaging and intraoperative cholangiogram, Kasai performed at 28 days. The question specifically asks about intraoperative findings predicting poor outcomes. Choice A (bile duct remnants <150 micrometers) is the established strongest histopathologic predictor of Kasai failure in the literature. This microscopic finding at the porta hepatis directly correlates with bile drainage success. Choice B (bridging fibrosis without cirrhosis) indicates advanced disease but is less predictive than duct remnant size. Choice C (CMV IgM) may worsen prognosis but is not the strongest predictor. Choice D (splenic malformation/polysplenia) represents biliary atresia splenic malformation syndrome with variable outcomes. Choice E (absent CBD with patent proximal ducts) actually suggests better anatomy for drainage, making it incorrect. The item is medically accurate, citing the well-established <150 micrometer threshold as the critical prognostic factor. All options are discriminable, and the keyed answer is uniquely defensible. Minimal fix: None needed; item is valid and accurate.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128-002", "question": "A 34-year-old woman is brought to the emergency department after a house fire. She was found unconscious in a closed room. On arrival, she is obtunded with GCS 8. Vital signs: BP 142/88 mmHg, HR 118 bpm, RR 28/min, SpO2 98% on 100% FiO2 via non-rebreather mask. Physical examination reveals cherry-red skin coloration, no visible burns, and no soot in the oropharynx. Arterial blood gas on 100% oxygen shows pH 7.18, PaCO2 28 mmHg, PaO2 487 mmHg, lactate 14 mmol/L. Carboxyhemoglobin level is 8%. Co-oximetry reveals an additional abnormal hemoglobin species at 18%. Which of the following is the most appropriate next step in management?", "options": ["Emergent hyperbaric oxygen therapy", "Intravenous hydroxocobalamin 5 grams", "Methylene blue 1-2 mg/kg intravenously", "Exchange transfusion", "Sodium thiosulfate 12.5 grams intravenously"], "answer": "B", "answer_index": 1, "explanation": "The clinical presentation with severe lactic acidosis, obtundation, relatively low carboxyhemoglobin but an additional abnormal hemoglobin species (18% methemoglobin-like reading which actually represents cyanohemoglobin on co-oximetry) in a fire victim strongly suggests cyanide toxicity from combustion of synthetic materials. Hydroxocobalamin is the first-line antidote for cyanide poisoning as it directly binds cyanide to form cyanocobalamin. Hyperbaric oxygen addresses CO toxicity but CO level is only 8%. Methylene blue treats methemoglobinemia but is contraindicated with cyanide. Sodium thiosulfate is slower acting and used as adjunct therapy.", "generator_model": "claude-opus-4-5-20251101", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Emergency Medicine", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: V. Verdict: Correct best answer. The vignette describes a fire victim with obtundation (GCS 8), severe metabolic acidosis (pH 7.18, lactate 14 mmol/L), and critically an 18% abnormal hemoglobin species on co-oximetry with only 8% carboxyhemoglobin. Key discriminating findings: (1) closed-space fire exposure, (2) profound lactic acidosis indicating cellular hypoxia despite high PaO2, (3) low COHb ruling out pure CO poisoning, (4) 18% abnormal species representing cyanohemoglobin from cyanide binding. This constellation is pathognomonic for cyanide toxicity from synthetic material combustion. Hydroxocobalamin (B) is the correct first-line antidote, directly binding cyanide to form cyanocobalamin. Alternative assessment: (A) Hyperbaric oxygen targets CO toxicity but COHb is only 8%, insufficient to explain severity; (C) Methylene blue treats methemoglobinemia but is contraindicated in cyanide poisoning as it worsens cellular hypoxia; (D) Exchange transfusion has no role in acute cyanide management; (E) Sodium thiosulfate is slower-acting adjunctive therapy, not first-line. The item is medically accurate and logically sound with one defensible best answer matching the key. Minimal fix: None needed; item is valid as written.\", \"medical_accuracy_score\": \"5\", \"logical_validity\": true, \"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best answer. The vignette describes a fire victim with obtundation (GCS 8), severe metabolic acidosis (pH 7.18, lactate 14 mmol/L), and critically an 18% abnormal hemoglobin species on co-oximetry with only 8% carboxyhemoglobin. Key discriminating findings: (1) closed-space fire exposure, (2) profound lactic acidosis indicating cellular hypoxia despite high PaO2, (3) low COHb ruling out pure CO poisoning, (4) 18% abnormal species representing cyanohemoglobin from cyanide binding. This constellation is pathognomonic for cyanide toxicity from synthetic material combustion. Hydroxocobalamin (B) is the correct first-line antidote, directly binding cyanide to form cyanocobalamin. Alternative assessment: (A) Hyperbaric oxygen targets CO toxicity but COHb is only 8%, insufficient to explain severity; (C) Methylene blue treats methemoglobinemia but is contraindicated in cyanide poisoning as it worsens cellular hypoxia; (D) Exchange transfusion has no role in acute cyanide management; (E) Sodium thiosulfate is slower-acting adjunctive therapy, not first-line. The item is medically accurate and logically sound with one defensible best answer matching the key. Minimal fix: None needed; item is valid as written.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128-003", "question": "A 58-year-old man with a history of chronic alcohol use disorder is undergoing emergency laparotomy for perforated duodenal ulcer. He received 4 units of packed red blood cells and 2 units of fresh frozen plasma intraoperatively. Thirty minutes after induction with propofol, fentanyl, and rocuronium, the anesthesiologist notes progressive hypotension (MAP 52 mmHg), tachycardia (128 bpm), elevated peak airway pressures (42 cmH2O), and oxygen desaturation to 88%. Central venous pressure has increased from 6 to 18 mmHg. There is no urticaria or angioedema. Bronchospasm is noted on auscultation. Serum tryptase drawn at this time returns elevated at 48 ng/mL (normal <11.4). Which of the following mechanisms most likely explains this patient's reaction?", "options": ["IgE-mediated mast cell degranulation to latex proteins", "Complement activation by anti-IgA antibodies", "Direct mast cell activation by neuromuscular blocking agent", "Bradykinin accumulation from C1-esterase inhibitor deficiency", "Transfusion-related acute lung injury from donor anti-HLA antibodies"], "answer": "C", "answer_index": 2, "explanation": "Neuromuscular blocking agents, particularly rocuronium, are the most common cause of perioperative anaphylaxis. They can cause direct (non-IgE mediated) mast cell degranulation through MRGPRX2 receptor activation, which explains the elevated tryptase, bronchospasm, and cardiovascular collapse without prior sensitization. IgA deficiency reactions typically present with urticaria and occur during transfusion. TRALI causes non-cardiogenic pulmonary edema without elevated tryptase or bronchospasm. Bradykinin-mediated angioedema does not cause bronchospasm or elevated tryptase. Latex allergy is less common and typically requires mucosal contact.", "generator_model": "claude-opus-4-5-20251101", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Anesthesiology", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: V. Verdict: Correct best answer. The vignette describes acute intraoperative anaphylaxis with hypotension, tachycardia, bronchospasm, elevated tryptase (48 ng/mL), and elevated CVP occurring 30 minutes post-induction with rocuronium. Key discriminating findings: (1) elevated tryptase confirms mast cell degranulation, (2) bronchospasm present, (3) no urticaria/angioedema, (4) rocuronium exposure, (5) cardiovascular collapse. Choice C (direct mast cell activation by NMBA) is the best answer—rocuronium can cause non-IgE-mediated degranulation via MRGPRX2 receptors, explaining elevated tryptase and bronchospasm without prior sensitization. Choice A (latex IgE) is less likely given no mucosal contact mentioned and rocuronium is more common. Choice B (anti-IgA) typically presents during transfusion with urticaria, not 30 minutes post-induction. Choice E (TRALI) causes non-cardiogenic pulmonary edema without elevated tryptase or bronchospasm. Choice D (bradykinin/C1-INH deficiency) causes angioedema without bronchospasm or elevated tryptase. Medical accuracy: Excellent—correctly identifies rocuronium as common perioperative anaphylaxis cause, accurate tryptase interpretation, proper mechanism (MRGPRX2). Minimal fix: None needed; item is valid and accurate.\", \"medical_accuracy_score\": \"5\", \"logical_validity\": true, \"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best answer. The vignette describes acute intraoperative anaphylaxis with hypotension, tachycardia, bronchospasm, elevated tryptase (48 ng/mL), and elevated CVP occurring 30 minutes post-induction with rocuronium. Key discriminating findings: (1) elevated tryptase confirms mast cell degranulation, (2) bronchospasm present, (3) no urticaria/angioedema, (4) rocuronium exposure, (5) cardiovascular collapse. Choice C (direct mast cell activation by NMBA) is the best answer—rocuronium can cause non-IgE-mediated degranulation via MRGPRX2 receptors, explaining elevated tryptase and bronchospasm without prior sensitization. Choice A (latex IgE) is less likely given no mucosal contact mentioned and rocuronium is more common. Choice B (anti-IgA) typically presents during transfusion with urticaria, not 30 minutes post-induction. Choice E (TRALI) causes non-cardiogenic pulmonary edema without elevated tryptase or bronchospasm. Choice D (bradykinin/C1-INH deficiency) causes angioedema without bronchospasm or elevated tryptase. Medical accuracy: Excellent—correctly identifies rocuronium as common perioperative anaphylaxis cause, accurate tryptase interpretation, proper mechanism (MRGPRX2). Minimal fix: None needed; item is valid and accurate.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128-004", "question": "A 72-year-old woman with severe aortic stenosis (valve area 0.6 cm², mean gradient 58 mmHg) and preserved ejection fraction is scheduled for transcatheter aortic valve replacement. During the procedure under general anesthesia, rapid ventricular pacing at 180 bpm is initiated for valve deployment. Immediately after pacing is terminated, the arterial line shows a pressure of 45/30 mmHg with a heart rate of 42 bpm. TEE reveals severe paravalvular regurgitation and a pericardial effusion of 1.8 cm with right atrial collapse. Which of the following is the most appropriate immediate intervention?", "options": ["Initiate cardiopulmonary bypass via femoral cannulation", "Administer atropine 1 mg and epinephrine 100 mcg", "Perform emergent pericardiocentesis via subxiphoid approach", "Deploy a second transcatheter valve within the first valve", "Initiate peripheral venoarterial extracorporeal membrane oxygenation"], "answer": "C", "answer_index": 2, "explanation": "The clinical picture demonstrates cardiac tamponade (pericardial effusion with right atrial collapse and profound hypotension) likely from annular rupture or wire perforation during TAVR. Emergent pericardiocentesis is the immediate life-saving intervention to relieve tamponade physiology. While VA-ECMO or cardiopulmonary bypass may ultimately be needed, pericardiocentesis can be performed immediately and may stabilize the patient. Pharmacologic support alone will not address the mechanical problem. Deploying a second valve does not address the tamponade and may worsen annular injury.", "generator_model": "claude-opus-4-5-20251101", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Anesthesiology", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: V. Verdict: Correct best answer. The stem describes a post-TAVR patient with classic cardiac tamponade physiology: profound hypotension (45/30 mmHg), bradycardia (42 bpm), 1.8 cm pericardial effusion with right atrial collapse on TEE. The discriminating findings are the hemodynamic collapse plus echocardiographic signs of tamponade (RA collapse). The most likely mechanism is annular rupture or wire perforation during the procedure. The keyed answer (C, emergent pericardiocentesis) is the immediate life-saving intervention for tamponade, addressing the mechanical obstruction to cardiac filling. Option A (CPB) and E (VA-ECMO) require more time to establish and don't directly relieve tamponade. Option B (atropine/epinephrine) addresses bradycardia/hypotension but not the underlying mechanical problem. Option D (second valve) doesn't address tamponade and risks worsening injury. The item is logically valid with a single defensible best answer matching the key. Medical accuracy is excellent: pericardiocentesis is the standard immediate intervention for tamponade, consistent with TAVR complication management guidelines. The clinical scenario is realistic and board-relevant. No fix needed; the item is well-constructed.\", \"medical_accuracy_score\": \"5\", \"logical_validity\": true, \"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best answer. The stem describes a post-TAVR patient with classic cardiac tamponade physiology: profound hypotension (45/30 mmHg), bradycardia (42 bpm), 1.8 cm pericardial effusion with right atrial collapse on TEE. The discriminating findings are the hemodynamic collapse plus echocardiographic signs of tamponade (RA collapse). The most likely mechanism is annular rupture or wire perforation during the procedure. The keyed answer (C, emergent pericardiocentesis) is the immediate life-saving intervention for tamponade, addressing the mechanical obstruction to cardiac filling. Option A (CPB) and E (VA-ECMO) require more time to establish and don't directly relieve tamponade. Option B (atropine/epinephrine) addresses bradycardia/hypotension but not the underlying mechanical problem. Option D (second valve) doesn't address tamponade and risks worsening injury. The item is logically valid with a single defensible best answer matching the key. Medical accuracy is excellent: pericardiocentesis is the standard immediate intervention for tamponade, consistent with TAVR complication management guidelines. The clinical scenario is realistic and board-relevant. No fix needed; the item is well-constructed.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128-005", "question": "A 28-year-old woman with treatment-resistant schizophrenia has been on clozapine 450 mg daily for 8 months with good symptom control. She presents with fever (39.2°C), sore throat, and malaise for 2 days. Laboratory studies reveal WBC 1,200/μL with absolute neutrophil count (ANC) 180/μL, hemoglobin 11.2 g/dL, and platelets 198,000/μL. Clozapine is immediately discontinued. After 14 days of supportive care including G-CSF, her ANC recovers to 2,400/μL. Given her excellent prior response to clozapine, the treatment team considers rechallenge. Which of the following factors most strongly contraindicates clozapine rechallenge in this patient?", "options": ["ANC nadir below 500/μL during the index episode", "Duration of neutropenia exceeding 10 days", "Concurrent use of G-CSF during recovery", "Time to ANC recovery exceeding 21 days from clozapine discontinuation", "Presence of fever during the neutropenic episode"], "answer": "A", "answer_index": 0, "explanation": "An ANC nadir below 500/μL (severe neutropenia/agranulocytosis) during clozapine-induced neutropenia is an absolute contraindication to rechallenge according to FDA guidelines and the Clozapine REMS program. Patients with ANC that dropped below 500/μL have a significantly higher risk of recurrent severe neutropenia with rechallenge. Duration of neutropenia, G-CSF use, recovery time, and presence of fever are concerning but do not absolutely contraindicate rechallenge if the nadir remained above 500/μL. The severity of the nadir is the critical determinant.", "generator_model": "claude-opus-4-5-20251101", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: V. Verdict: Correct best answer. The vignette describes clozapine-induced agranulocytosis (ANC 180/μL, well below 500/μL) in a patient with treatment-resistant schizophrenia. The question asks which factor most strongly contraindicates rechallenge. Key discriminating finding: ANC nadir of 180/μL. FDA/REMS guidelines establish ANC <500/μL as an absolute contraindication to clozapine rechallenge due to high recurrence risk. Option A correctly identifies this threshold. Option B (duration >10 days) is concerning but not an absolute contraindication per guidelines. Option C (G-CSF use) is supportive care, not a contraindication factor. Option D (recovery >21 days) - the vignette states 14 days, making this factually inapplicable. Option E (fever) suggests infection risk but doesn't independently contraindicate rechallenge if ANC nadir was adequate. The item is medically accurate, citing established REMS criteria. The stem provides sufficient detail (specific ANC nadir) to discriminate among options. No logical flaws or ambiguity exist. Minimal fix: None needed; item is valid and accurate.\", \"medical_accuracy_score\": \"5\", \"logical_validity\": true, \"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best answer. The vignette describes clozapine-induced agranulocytosis (ANC 180/μL, well below 500/μL) in a patient with treatment-resistant schizophrenia. The question asks which factor most strongly contraindicates rechallenge. Key discriminating finding: ANC nadir of 180/μL. FDA/REMS guidelines establish ANC <500/μL as an absolute contraindication to clozapine rechallenge due to high recurrence risk. Option A correctly identifies this threshold. Option B (duration >10 days) is concerning but not an absolute contraindication per guidelines. Option C (G-CSF use) is supportive care, not a contraindication factor. Option D (recovery >21 days) - the vignette states 14 days, making this factually inapplicable. Option E (fever) suggests infection risk but doesn't independently contraindicate rechallenge if ANC nadir was adequate. The item is medically accurate, citing established REMS criteria. The stem provides sufficient detail (specific ANC nadir) to discriminate among options. No logical flaws or ambiguity exist. Minimal fix: None needed; item is valid and accurate.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128-006", "question": "A 45-year-old man with bipolar I disorder, currently euthymic on lithium monotherapy (level 0.9 mEq/L), develops new-onset nephrotic syndrome. Renal biopsy reveals minimal change disease. His nephrologist initiates prednisone 60 mg daily. Two weeks later, he presents with decreased need for sleep, pressured speech, grandiosity, and impulsive spending. Lithium level is 0.7 mEq/L. Which of the following is the most appropriate next step in management?", "options": ["Increase lithium dose to achieve level of 1.2 mEq/L", "Add valproic acid 500 mg twice daily", "Add olanzapine 10 mg at bedtime", "Discontinue prednisone and switch to cyclosporine", "Add lamotrigine 25 mg daily with gradual titration"], "answer": "C", "answer_index": 2, "explanation": "This patient has developed corticosteroid-induced mania, a well-recognized complication of high-dose glucocorticoid therapy. The most appropriate acute intervention is adding an atypical antipsychotic such as olanzapine, which has rapid antimanic efficacy and is FDA-approved for acute mania. Increasing lithium is problematic given nephrotic syndrome and potential nephrotoxicity. Valproic acid has hepatic and hematologic concerns with concurrent steroid use. Abruptly discontinuing prednisone could cause nephrotic syndrome relapse and adrenal insufficiency. Lamotrigine has no acute antimanic efficacy and requires slow titration.", "generator_model": "claude-opus-4-5-20251101", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V. Verdict: Correct best answer. The stem describes a 45-year-old man with bipolar I disorder on lithium who develops corticosteroid-induced mania after starting prednisone 60 mg daily for minimal change disease. Key discriminating findings: (1) acute manic symptoms (decreased sleep, pressured speech, grandiosity, impulsive spending) temporally linked to high-dose steroid initiation; (2) lithium level dropped from 0.9 to 0.7 mEq/L (subtherapeutic); (3) active nephrotic syndrome with ongoing need for immunosuppression. The clinical problem is managing acute mania in a patient requiring continued steroid therapy with compromised renal function. Option C (olanzapine) is the best answer: atypical antipsychotics provide rapid antimanic efficacy, are FDA-approved for acute mania, and avoid renal concerns. Option A is problematic given nephrotic syndrome and lithium nephrotoxicity risk. Option B (valproate) has slower onset and potential drug interactions with steroids. Option D risks nephrotic relapse and adrenal crisis from abrupt steroid withdrawal. Option E (lamotrigine) lacks acute antimanic efficacy and requires slow titration (weeks to months). The item is logically valid with clear stem-to-answer pathway. Medical accuracy is high: corticosteroid-induced mania is well-documented, and atypical antipsychotics are standard acute treatment. Minimal fix: none needed; item is defensible as written.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best answer. The stem describes a 45-year-old man with bipolar I disorder on lithium who develops corticosteroid-induced mania after starting prednisone 60 mg daily for minimal change disease. Key discriminating findings: (1) acute manic symptoms (decreased sleep, pressured speech, grandiosity, impulsive spending) temporally linked to high-dose steroid initiation; (2) lithium level dropped from 0.9 to 0.7 mEq/L (subtherapeutic); (3) active nephrotic syndrome with ongoing need for immunosuppression. The clinical problem is managing acute mania in a patient requiring continued steroid therapy with compromised renal function. Option C (olanzapine) is the best answer: atypical antipsychotics provide rapid antimanic efficacy, are FDA-approved for acute mania, and avoid renal concerns. Option A is problematic given nephrotic syndrome and lithium nephrotoxicity risk. Option B (valproate) has slower onset and potential drug interactions with steroids. Option D risks nephrotic relapse and adrenal crisis from abrupt steroid withdrawal. Option E (lamotrigine) lacks acute antimanic efficacy and requires slow titration (weeks to months). The item is logically valid with clear stem-to-answer pathway. Medical accuracy is high: corticosteroid-induced mania is well-documented, and atypical antipsychotics are standard acute treatment. Minimal fix: none needed; item is defensible as written.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128-007", "question": "A 32-year-old woman is brought to the psychiatric emergency department by police after being found wandering naked in a shopping mall, speaking in rhymes, and claiming to be receiving messages from television broadcasts. She has no psychiatric history. Toxicology screen is negative. Physical examination reveals a fine resting tremor, tachycardia (112 bpm), and lid lag. TSH is <0.01 mIU/L, free T4 is 6.8 ng/dL (normal 0.8-1.8), and free T3 is 18.2 pg/mL (normal 2.3-4.2). After initial stabilization with propranolol and methimazole, her psychotic symptoms persist at day 10 despite normalized heart rate. Which of the following antipsychotic medications carries the highest risk of worsening her underlying medical condition?", "options": ["Haloperidol", "Risperidone", "Quetiapine", "Aripiprazole", "Ziprasidone"], "answer": "C", "answer_index": 2, "explanation": "This patient has thyrotoxicosis-induced psychosis (thyroid storm with neuropsychiatric manifestations). Quetiapine has significant anticholinergic properties that can impair heat dissipation and worsen hyperthermia, which is particularly dangerous in thyroid storm where temperature dysregulation is already compromised. Additionally, quetiapine's alpha-adrenergic blockade can cause orthostatic hypotension, complicating the hemodynamic instability of thyrotoxicosis. Haloperidol, while having some risk of hyperthermia, has less anticholinergic activity. Risperidone, aripiprazole, and ziprasidone have minimal anticholinergic effects.", "generator_model": "claude-opus-4-5-20251101", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: K (Miskeyed). Verdict: Miskeyed – Haloperidol is the correct answer, not Quetiapine. The stem describes thyrotoxicosis-induced psychosis requiring antipsychotic treatment. Key discriminating findings: psychosis, hyperthyroidism (TSH <0.01, elevated T4/T3), tachycardia, tremor, lid lag, persistent psychosis at day 10 despite beta-blockade and methimazole. The question asks which antipsychotic carries highest risk of worsening the underlying condition (thyrotoxicosis). Haloperidol (A) is well-documented to worsen thyroid storm through multiple mechanisms: dopamine antagonism increases TRH/TSH secretion, can precipitate neuroleptic malignant syndrome (NMS) with hyperthermia mimicking/worsening thyroid storm, and has significant risk of QTc prolongation in thyrotoxic patients already at arrhythmia risk. The rationale's focus on quetiapine's anticholinergic effects causing hyperthermia is medically questionable – quetiapine has relatively LOW anticholinergic activity compared to other antipsychotics, and anticholinergic-induced hyperthermia is not a primary concern in thyrotoxicosis management. The rationale conflates mechanisms. Standard teaching: avoid typical antipsychotics (especially haloperidol) in thyroid storm; prefer atypical agents with lower D2 antagonism. Minimal fix: Change key to A (Haloperidol) and revise rationale to address NMS risk, dopaminergic effects on thyroid axis, and arrhythmia risk.\", \"medical_accuracy_score\": \"2\", \"logical_validity\": false, \"logical_false_reason\": \"K\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed). Verdict: Miskeyed – Haloperidol is the correct answer, not Quetiapine. The stem describes thyrotoxicosis-induced psychosis requiring antipsychotic treatment. Key discriminating findings: psychosis, hyperthyroidism (TSH <0.01, elevated T4/T3), tachycardia, tremor, lid lag, persistent psychosis at day 10 despite beta-blockade and methimazole. The question asks which antipsychotic carries highest risk of worsening the underlying condition (thyrotoxicosis). Haloperidol (A) is well-documented to worsen thyroid storm through multiple mechanisms: dopamine antagonism increases TRH/TSH secretion, can precipitate neuroleptic malignant syndrome (NMS) with hyperthermia mimicking/worsening thyroid storm, and has significant risk of QTc prolongation in thyrotoxic patients already at arrhythmia risk. The rationale's focus on quetiapine's anticholinergic effects causing hyperthermia is medically questionable – quetiapine has relatively LOW anticholinergic activity compared to other antipsychotics, and anticholinergic-induced hyperthermia is not a primary concern in thyrotoxicosis management. The rationale conflates mechanisms. Standard teaching: avoid typical antipsychotics (especially haloperidol) in thyroid storm; prefer atypical agents with lower D2 antagonism. Minimal fix: Change key to A (Haloperidol) and revise rationale to address NMS risk, dopaminergic effects on thyroid axis, and arrhythmia risk.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128-008", "question": "A 67-year-old man undergoes elective right hemicolectomy for a cecal adenocarcinoma. On postoperative day 3, he develops fever (38.9°C), tachycardia, and diffuse abdominal tenderness with guarding. CT scan reveals free air, a 4-cm fluid collection near the ileocolic anastomosis, and no contrast extravasation on oral contrast study. Laboratory studies show WBC 18,400/μL and lactate 3.2 mmol/L. At re-exploration, the anastomosis appears intact but edematous with surrounding fibrinous exudate. There is 400 mL of turbid fluid in the peritoneal cavity. Gram stain of the fluid shows gram-negative rods and gram-positive cocci in chains. Which of the following is the most appropriate surgical management?", "options": ["Washout with drain placement and preservation of anastomosis", "Takedown of anastomosis with end ileostomy and mucous fistula", "Takedown of anastomosis with end ileostomy and Hartmann's pouch", "Resection of anastomosis with primary re-anastomosis and proximal diverting loop ileostomy", "Washout with omental patch reinforcement of anastomosis"], "answer": "B", "answer_index": 1, "explanation": "This patient has an anastomotic leak with peritonitis despite the anastomosis appearing grossly intact (contained leak with surrounding contamination). In the setting of generalized peritonitis, hemodynamic compromise (tachycardia, elevated lactate), and polymicrobial contamination, the safest approach is takedown of the anastomosis with end ileostomy and mucous fistula. This is preferred over Hartmann's pouch because the distal bowel (ascending/transverse colon) is healthy and can be exteriorized. Preserving the anastomosis or performing primary re-anastomosis in this contaminated, inflamed field carries unacceptable leak risk.", "generator_model": "claude-opus-4-5-20251101", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "General Surgery", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: V. Verdict: Correct best answer. The vignette describes postoperative day 3 fever, peritonitis signs (diffuse tenderness, guarding), elevated WBC/lactate, free air, peri-anastomotic fluid collection, and polymicrobial peritoneal contamination found at re-exploration. Key discriminating findings: (1) systemic signs of sepsis (fever, tachycardia, lactate 3.2), (2) generalized peritonitis, (3) polymicrobial contamination (400 mL turbid fluid), (4) anastomosis appears intact but surrounded by inflammation/exudate (contained leak). The clinical problem is managing an anastomotic leak with generalized peritonitis in a physiologically stressed patient. Option B (takedown with end ileostomy and mucous fistula) is the safest damage-control approach: eliminates the compromised anastomosis, diverts fecal stream, and allows exteriorization of healthy distal colon. Option A risks re-leak in contaminated field. Option C (Hartmann's) is less ideal when distal bowel is healthy and can be exteriorized. Option D (re-anastomosis with diversion) still leaves an anastomosis in contaminated/inflamed tissue with high re-leak risk. Option E (omental patch) inadequately addresses established peritonitis and leak. The keyed answer aligns with damage-control surgery principles for anastomotic leak with peritonitis. No logical flaws or medical inaccuracies detected. Minimal fix: none needed; item is valid as written.\", \"medical_accuracy_score\": \"5\", \"logical_validity\": true, \"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best answer. The vignette describes postoperative day 3 fever, peritonitis signs (diffuse tenderness, guarding), elevated WBC/lactate, free air, peri-anastomotic fluid collection, and polymicrobial peritoneal contamination found at re-exploration. Key discriminating findings: (1) systemic signs of sepsis (fever, tachycardia, lactate 3.2), (2) generalized peritonitis, (3) polymicrobial contamination (400 mL turbid fluid), (4) anastomosis appears intact but surrounded by inflammation/exudate (contained leak). The clinical problem is managing an anastomotic leak with generalized peritonitis in a physiologically stressed patient. Option B (takedown with end ileostomy and mucous fistula) is the safest damage-control approach: eliminates the compromised anastomosis, diverts fecal stream, and allows exteriorization of healthy distal colon. Option A risks re-leak in contaminated field. Option C (Hartmann's) is less ideal when distal bowel is healthy and can be exteriorized. Option D (re-anastomosis with diversion) still leaves an anastomosis in contaminated/inflamed tissue with high re-leak risk. Option E (omental patch) inadequately addresses established peritonitis and leak. The keyed answer aligns with damage-control surgery principles for anastomotic leak with peritonitis. No logical flaws or medical inaccuracies detected. Minimal fix: none needed; item is valid as written.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128-009", "question": "A 52-year-old woman with BMI 48 kg/m² undergoes laparoscopic Roux-en-Y gastric bypass. Eighteen months postoperatively, she has lost 95 pounds and presents with recurrent episodes of postprandial confusion, diaphoresis, and tremor that resolve with eating. Symptoms occur 2-3 hours after meals, particularly those high in simple carbohydrates. Fasting glucose is 78 mg/dL. A mixed meal tolerance test demonstrates glucose of 42 mg/dL with insulin of 28 μU/mL and C-peptide of 6.2 ng/mL at 120 minutes. Calcium-stimulated angiography and selective arterial calcium stimulation testing are negative for insulinoma. Which of the following is the most appropriate next step in management?", "options": ["Diazoxide 100 mg three times daily", "Octreotide 100 mcg subcutaneously before meals", "Acarbose 50 mg with meals", "Completion pancreatectomy", "Reversal of gastric bypass to normal anatomy"], "answer": "C", "answer_index": 2, "explanation": "This patient has post-bariatric hypoglycemia (previously called late dumping syndrome or noninsulinoma pancreatogenous hypoglycemia syndrome). The pathophysiology involves exaggerated GLP-1 secretion leading to inappropriate insulin release after rapid glucose absorption. Acarbose, an alpha-glucosidase inhibitor, slows carbohydrate absorption and reduces the glycemic spike that triggers excessive insulin secretion. It is first-line medical therapy. Diazoxide and octreotide are second-line options with more side effects. Pancreatectomy is reserved for refractory cases. Reversal surgery has high morbidity and variable efficacy.", "generator_model": "claude-opus-4-5-20251101", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "General Surgery", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: V. Verdict: Correct best answer. The vignette describes classic post-bariatric hypoglycemia (PBH) after Roux-en-Y gastric bypass: postprandial hypoglycemic symptoms 2-3 hours after meals (especially high-carbohydrate), resolution with eating, documented hypoglycemia (42 mg/dL) with inappropriately elevated insulin (28 μU/mL) and C-peptide (6.2 ng/mL), and negative insulinoma workup. Key discriminating findings: timing (late postprandial), post-RYGB status, hyperinsulinemic hypoglycemia, negative localization studies. Acarbose (C) is the established first-line medical therapy, slowing carbohydrate absorption to blunt the glycemic spike that triggers excessive GLP-1/insulin secretion. Diazoxide (A) and octreotide (B) are second-line with more adverse effects. Completion pancreatectomy (D) is reserved for medically refractory cases and carries significant morbidity (diabetes, exocrine insufficiency). Reversal surgery (E) has high morbidity and inconsistent efficacy, reserved for severe refractory cases. The item is logically valid with one defensible best answer matching the key. Medical accuracy is excellent, reflecting current management guidelines for PBH. No contradictions or underspecification. Minimal fix: None needed; item is well-constructed.\", \"medical_accuracy_score\": \"5\", \"logical_validity\": true, \"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best answer. The vignette describes classic post-bariatric hypoglycemia (PBH) after Roux-en-Y gastric bypass: postprandial hypoglycemic symptoms 2-3 hours after meals (especially high-carbohydrate), resolution with eating, documented hypoglycemia (42 mg/dL) with inappropriately elevated insulin (28 μU/mL) and C-peptide (6.2 ng/mL), and negative insulinoma workup. Key discriminating findings: timing (late postprandial), post-RYGB status, hyperinsulinemic hypoglycemia, negative localization studies. Acarbose (C) is the established first-line medical therapy, slowing carbohydrate absorption to blunt the glycemic spike that triggers excessive GLP-1/insulin secretion. Diazoxide (A) and octreotide (B) are second-line with more adverse effects. Completion pancreatectomy (D) is reserved for medically refractory cases and carries significant morbidity (diabetes, exocrine insufficiency). Reversal surgery (E) has high morbidity and inconsistent efficacy, reserved for severe refractory cases. The item is logically valid with one defensible best answer matching the key. Medical accuracy is excellent, reflecting current management guidelines for PBH. No contradictions or underspecification. Minimal fix: None needed; item is well-constructed.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128-010", "question": "A 58-year-old man with type 2 diabetes presents with sudden painless vision loss in his right eye upon awakening. Best-corrected visual acuity is 20/200 OD and 20/25 OS. Funduscopic examination of the right eye reveals diffuse retinal whitening with a cherry-red spot at the macula, attenuated arterioles, and segmentation of blood columns (\"boxcarring\"). Intraocular pressure is 14 mmHg OD and 15 mmHg OS. Carotid duplex shows 40% stenosis of the right internal carotid artery. Echocardiogram reveals no intracardiac thrombus. The patient presents 3 hours after symptom onset. Which of the following interventions has the strongest evidence for visual recovery in this condition?", "options": ["Anterior chamber paracentesis to lower intraocular pressure", "Intravenous tissue plasminogen activator", "Hyperbaric oxygen therapy", "Intra-arterial thrombolysis via ophthalmic artery catheterization", "Conservative management with secondary stroke prevention"], "answer": "E", "answer_index": 4, "explanation": "This patient has central retinal artery occlusion (CRAO). Despite numerous proposed interventions including ocular massage, anterior chamber paracentesis, carbogen inhalation, IV or intra-arterial thrombolysis, and hyperbaric oxygen, no treatment has demonstrated consistent efficacy in randomized controlled trials for improving visual outcomes in CRAO. The EAGLE study found no benefit of intra-arterial thrombolysis. Current evidence supports conservative management with urgent evaluation and treatment for stroke risk factors, as CRAO is considered a stroke equivalent. Secondary prevention with antiplatelet therapy and risk factor modification is the evidence-based approach.", "generator_model": "claude-opus-4-5-20251101", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Ophthalmology", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: V. Verdict: Correct best answer. The vignette describes classic central retinal artery occlusion (CRAO) with pathognomonic findings: sudden painless vision loss, diffuse retinal whitening, cherry-red spot, attenuated arterioles, and boxcarring. The 3-hour presentation window is noted. Key discriminating clues: (1) classic CRAO presentation, (2) 40% carotid stenosis (embolic source), (3) no cardiac thrombus, (4) 3-hour window. The question asks for strongest evidence for visual recovery. Option E (conservative management with secondary stroke prevention) is correct because multiple RCTs, including the EAGLE trial, have failed to demonstrate benefit from interventions like thrombolysis, paracentesis, or hyperbaric oxygen. CRAO is now recognized as a stroke equivalent requiring urgent stroke workup and secondary prevention. Options A-D all lack robust RCT evidence for visual recovery despite historical use. The stem provides sufficient detail to identify CRAO and recognize the evidence gap for acute interventions. Medical accuracy: The teaching point correctly reflects current ophthalmology and neurology consensus that no acute intervention has proven efficacy, and management focuses on stroke prevention. Minimal fix: None needed; item is logically valid and medically accurate.\", \"medical_accuracy_score\": \"5\", \"logical_validity\": true, \"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best answer. The vignette describes classic central retinal artery occlusion (CRAO) with pathognomonic findings: sudden painless vision loss, diffuse retinal whitening, cherry-red spot, attenuated arterioles, and boxcarring. The 3-hour presentation window is noted. Key discriminating clues: (1) classic CRAO presentation, (2) 40% carotid stenosis (embolic source), (3) no cardiac thrombus, (4) 3-hour window. The question asks for strongest evidence for visual recovery. Option E (conservative management with secondary stroke prevention) is correct because multiple RCTs, including the EAGLE trial, have failed to demonstrate benefit from interventions like thrombolysis, paracentesis, or hyperbaric oxygen. CRAO is now recognized as a stroke equivalent requiring urgent stroke workup and secondary prevention. Options A-D all lack robust RCT evidence for visual recovery despite historical use. The stem provides sufficient detail to identify CRAO and recognize the evidence gap for acute interventions. Medical accuracy: The teaching point correctly reflects current ophthalmology and neurology consensus that no acute intervention has proven efficacy, and management focuses on stroke prevention. Minimal fix: None needed; item is logically valid and medically accurate.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128-011", "question": "A 6-year-old boy presents with progressive gait instability, frequent falls, and difficulty climbing stairs over the past year. Physical examination reveals calf pseudohypertrophy, positive Gowers' sign, and proximal muscle weakness. Creatine kinase is 15,400 U/L. Genetic testing confirms a deletion in the dystrophin gene consistent with Duchenne muscular dystrophy. Echocardiogram shows normal left ventricular function. The family asks about disease-modifying therapy. The child weighs 22 kg. Which of the following treatments is most likely to slow disease progression in this patient?", "options": ["Deflazacort 0.9 mg/kg/day", "Eteplirsen 30 mg/kg weekly intravenously", "Ataluren 40 mg/kg/day in three divided doses", "Golodirsen 30 mg/kg weekly intravenously", "Idebenone 900 mg daily"], "answer": "A", "answer_index": 0, "explanation": "Deflazacort (and prednisone) are the only treatments with robust evidence demonstrating slowed disease progression in Duchenne muscular dystrophy, including prolonged ambulation, preserved pulmonary function, and delayed cardiomyopathy. Deflazacort may have a slightly better side effect profile than prednisone. Exon-skipping therapies (eteplirsen, golodirsen) are only applicable to specific mutations amenable to exon skipping and have shown only modest dystrophin production without clear clinical benefit. Ataluren is for nonsense mutations only. Idebenone showed no benefit in the DELOS trial for patients on corticosteroids.", "generator_model": "claude-opus-4-5-20251101", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: V. Verdict: Correct best answer. The stem describes a classic DMD presentation (6-year-old boy, progressive proximal weakness, Gowers' sign, calf pseudohypertrophy, markedly elevated CK 15,400 U/L, dystrophin deletion). The question asks for disease-modifying therapy to slow progression. Key discriminating findings: confirmed DMD with deletion mutation, normal cardiac function, 22 kg weight, age 6. Deflazacort 0.9 mg/kg/day (A) is the keyed answer and represents corticosteroid therapy, which has Level 1 evidence for slowing DMD progression (prolonged ambulation, preserved pulmonary/cardiac function). This is standard of care per DMD Care Considerations. The dose is appropriate. Alternative assessment: (B) Eteplirsen and (D) Golodirsen are exon-skipping therapies for specific amenable mutations (exons 51 and 53 respectively); the stem doesn't specify which exon is deleted, making mutation-specific therapy selection impossible without that detail. (C) Ataluren is only for nonsense mutations, not deletions. (E) Idebenone lacks efficacy evidence in DMD patients on corticosteroids. While the stem is technically underspecified regarding which exon is deleted (limiting assessment of exon-skipping eligibility), corticosteroids remain first-line disease-modifying therapy regardless of mutation type, making deflazacort the universally applicable best answer. No logical flaws prevent unique best-answer selection. Minimal fix: specify deleted exon number to fully justify excluding mutation-specific therapies.\", \"medical_accuracy_score\": \"5\", \"logical_validity\": true, \"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best answer. The stem describes a classic DMD presentation (6-year-old boy, progressive proximal weakness, Gowers' sign, calf pseudohypertrophy, markedly elevated CK 15,400 U/L, dystrophin deletion). The question asks for disease-modifying therapy to slow progression. Key discriminating findings: confirmed DMD with deletion mutation, normal cardiac function, 22 kg weight, age 6. Deflazacort 0.9 mg/kg/day (A) is the keyed answer and represents corticosteroid therapy, which has Level 1 evidence for slowing DMD progression (prolonged ambulation, preserved pulmonary/cardiac function). This is standard of care per DMD Care Considerations. The dose is appropriate. Alternative assessment: (B) Eteplirsen and (D) Golodirsen are exon-skipping therapies for specific amenable mutations (exons 51 and 53 respectively); the stem doesn't specify which exon is deleted, making mutation-specific therapy selection impossible without that detail. (C) Ataluren is only for nonsense mutations, not deletions. (E) Idebenone lacks efficacy evidence in DMD patients on corticosteroids. While the stem is technically underspecified regarding which exon is deleted (limiting assessment of exon-skipping eligibility), corticosteroids remain first-line disease-modifying therapy regardless of mutation type, making deflazacort the universally applicable best answer. No logical flaws prevent unique best-answer selection. Minimal fix: specify deleted exon number to fully justify excluding mutation-specific therapies.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128-012", "question": "A 24-year-old man is brought to the emergency department after being rescued from a house fire. He has extensive full-thickness burns covering an estimated 65% total body surface area. He is intubated in the field for airway protection. Initial resuscitation is begun with lactated Ringer's solution using the Parkland formula. Six hours into resuscitation, he has received 14 liters of crystalloid. Vital signs: BP 88/52 mmHg, HR 132 bpm. Urine output over the past 2 hours is 15 mL total. Bladder pressure is 32 mmHg. Peak airway pressures have increased from 28 to 48 cmH2O. Which of the following is the most appropriate next step?", "options": ["Increase crystalloid infusion rate by 50%", "Add albumin 5% to resuscitation fluids", "Perform bilateral chest escharotomies", "Perform decompressive laparotomy", "Perform bedside abdominal escharotomy"], "answer": "E", "answer_index": 4, "explanation": "This patient has developed abdominal compartment syndrome (ACS) in the setting of massive burn resuscitation, evidenced by oliguria, hypotension, elevated bladder pressure (>20 mmHg with organ dysfunction), and elevated airway pressures. In burn patients with circumferential or near-circumferential truncal burns, abdominal escharotomy can effectively decompress the abdomen without the morbidity of laparotomy. This should be attempted before decompressive laparotomy. Increasing crystalloid will worsen edema and compartment pressures. Chest escharotomies address thoracic restriction but not abdominal compartment syndrome. Albumin may reduce total fluid requirements but won't acutely address ACS.", "generator_model": "claude-opus-4-5-20251101", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Emergency Medicine", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: V. Verdict: Correct best answer. The stem describes a 24-year-old burn patient (65% TBSA) six hours into resuscitation presenting with classic abdominal compartment syndrome (ACS): bladder pressure 32 mmHg (diagnostic threshold >20 mmHg), oliguria (15 mL/2 hours, <0.5 mL/kg/hr), hypotension, tachycardia, and rising peak airway pressures (28→48 cmH2O). Key discriminating findings: elevated intra-abdominal pressure with multi-organ dysfunction in a massive burn requiring aggressive fluid resuscitation. The question asks for the most appropriate next step. Option E (abdominal escharotomy) is correct for burn-related ACS with circumferential/near-circumferential truncal eschar—it provides immediate decompression with lower morbidity than laparotomy. Option D (laparotomy) is reserved for refractory cases or non-burn ACS. Option C addresses thoracic restriction, not abdominal compartment syndrome. Options A-B worsen the underlying problem by increasing fluid/edema. The stem provides sufficient detail (burn extent, bladder pressure, organ dysfunction) to identify ACS and select the burn-specific intervention. Medical accuracy: fully consistent with burn/trauma critical care guidelines. Minimal fix: none needed; item is valid and accurate.\", \"medical_accuracy_score\": \"5\", \"logical_validity\": true, \"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best answer. The stem describes a 24-year-old burn patient (65% TBSA) six hours into resuscitation presenting with classic abdominal compartment syndrome (ACS): bladder pressure 32 mmHg (diagnostic threshold >20 mmHg), oliguria (15 mL/2 hours, <0.5 mL/kg/hr), hypotension, tachycardia, and rising peak airway pressures (28→48 cmH2O). Key discriminating findings: elevated intra-abdominal pressure with multi-organ dysfunction in a massive burn requiring aggressive fluid resuscitation. The question asks for the most appropriate next step. Option E (abdominal escharotomy) is correct for burn-related ACS with circumferential/near-circumferential truncal eschar—it provides immediate decompression with lower morbidity than laparotomy. Option D (laparotomy) is reserved for refractory cases or non-burn ACS. Option C addresses thoracic restriction, not abdominal compartment syndrome. Options A-B worsen the underlying problem by increasing fluid/edema. The stem provides sufficient detail (burn extent, bladder pressure, organ dysfunction) to identify ACS and select the burn-specific intervention. Medical accuracy: fully consistent with burn/trauma critical care guidelines. Minimal fix: none needed; item is valid and accurate.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128-013", "question": "A 45-year-old woman with myasthenia gravis (anti-acetylcholine receptor antibody positive) on pyridostigmine and prednisone is scheduled for thymectomy. She reports mild dyspnea with exertion and occasional dysphagia. Forced vital capacity is 1.8 L (62% predicted). On the morning of surgery, she takes her usual pyridostigmine dose. After uneventful induction with propofol and fentanyl, the anesthesiologist administers rocuronium 0.6 mg/kg for intubation. The surgery proceeds without complication. At the end of the case, train-of-four monitoring shows 2/4 twitches. Sugammadex 4 mg/kg is administered. Five minutes later, train-of-four ratio is 0.95 and the patient is extubated. In the PACU, she develops progressive respiratory distress, paradoxical breathing, and oxygen desaturation. ABG shows pH 7.28, PaCO2 62 mmHg, PaO2 58 mmHg on 6L nasal cannula. Which of the following is the most likely cause of her respiratory failure?", "options": ["Residual neuromuscular blockade from rocuronium", "Sugammadex-induced anaphylaxis", "Myasthenic crisis precipitated by surgical stress", "Cholinergic crisis from pyridostigmine", "Unilateral phrenic nerve injury during thymectomy"], "answer": "C", "answer_index": 2, "explanation": "This patient is experiencing myasthenic crisis, an exacerbation of myasthenia gravis causing respiratory failure. Surgical stress, particularly thymectomy, is a well-known precipitant. The adequate train-of-four ratio (0.95) after sugammadex rules out residual neuromuscular blockade. Sugammadex anaphylaxis would present with cardiovascular collapse and bronchospasm, not isolated hypercapnic respiratory failure. Cholinergic crisis would present with excessive secretions, miosis, bradycardia, and fasciculations. Unilateral phrenic nerve injury rarely causes this degree of respiratory compromise. The hypercapnic respiratory failure pattern indicates neuromuscular weakness affecting respiratory muscles.", "generator_model": "claude-opus-4-5-20251101", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Anesthesiology", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: M (Multiple answers defensible). Verdict: Not uniquely determinable. The stem describes a post-thymectomy MG patient with respiratory failure showing hypercapnic pattern (pH 7.28, PaCO2 62). Key discriminating findings: TOF 0.95 post-sugammadex, progressive distress in PACU, paradoxical breathing, hypercapnic failure. The keyed answer (C, myasthenic crisis) is plausible given surgical stress as precipitant. However, option A (residual NMB) is equally defensible despite TOF 0.95 because: (1) MG patients have increased sensitivity to NMDAs requiring reduced dosing—0.6 mg/kg rocuronium is standard dosing, not reduced; (2) TOF ratio 0.95 doesn't exclude clinically significant weakness in MG patients who may need >0.95 for adequate strength; (3) the timeline (immediate post-extubation failure) and hypercapnic pattern fit residual weakness; (4) paradoxical breathing is classic for diaphragmatic weakness from incomplete reversal. The item requires assuming TOF 0.95 definitively excludes NMB in an MG patient—an unstated assumption not universally accepted. Both A and C explain the clinical picture; no stem clue definitively discriminates between inadequately reversed NMB in a sensitive patient versus acute myasthenic crisis. Minimal fix: Add explicit preoperative weakness severity markers or specify TOF >0.98 with sustained tetanus to better exclude residual blockade.\", \"medical_accuracy_score\": \"4\", \"logical_validity\": false, \"logical_false_reason\": \"M\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: M (Multiple answers defensible). Verdict: Not uniquely determinable. The stem describes a post-thymectomy MG patient with respiratory failure showing hypercapnic pattern (pH 7.28, PaCO2 62). Key discriminating findings: TOF 0.95 post-sugammadex, progressive distress in PACU, paradoxical breathing, hypercapnic failure. The keyed answer (C, myasthenic crisis) is plausible given surgical stress as precipitant. However, option A (residual NMB) is equally defensible despite TOF 0.95 because: (1) MG patients have increased sensitivity to NMDAs requiring reduced dosing—0.6 mg/kg rocuronium is standard dosing, not reduced; (2) TOF ratio 0.95 doesn't exclude clinically significant weakness in MG patients who may need >0.95 for adequate strength; (3) the timeline (immediate post-extubation failure) and hypercapnic pattern fit residual weakness; (4) paradoxical breathing is classic for diaphragmatic weakness from incomplete reversal. The item requires assuming TOF 0.95 definitively excludes NMB in an MG patient—an unstated assumption not universally accepted. Both A and C explain the clinical picture; no stem clue definitively discriminates between inadequately reversed NMB in a sensitive patient versus acute myasthenic crisis. Minimal fix: Add explicit preoperative weakness severity markers or specify TOF >0.98 with sustained tetanus to better exclude residual blockade.", "medical_accuracy_score": 4, "logical_validity": false, "logical_false_reason": "M", "verdict": "FAIL", "fail_reason": "M"}, "judge_verdict": "FAIL", "judge_fail_reason": "M", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128-014", "question": "A 68-year-old man with severe COPD (FEV1 28% predicted) undergoes right upper lobectomy for non-small cell lung cancer under general anesthesia with one-lung ventilation using a left-sided double-lumen tube. During one-lung ventilation of the left lung, SpO2 drops to 84% despite FiO2 1.0. Fiberoptic bronchoscopy confirms correct tube position. Tidal volume is 350 mL, respiratory rate 14/min, PEEP 5 cmH2O. Peak airway pressure is 38 cmH2O. ABG shows PaO2 52 mmHg, PaCO2 58 mmHg. Which of the following interventions is most likely to improve oxygenation?", "options": ["Apply CPAP 5 cmH2O to the non-ventilated (operative) lung", "Increase PEEP to 10 cmH2O on the ventilated lung", "Increase tidal volume to 500 mL", "Administer inhaled nitric oxide to the ventilated lung", "Clamp the pulmonary artery of the operative lung"], "answer": "A", "answer_index": 0, "explanation": "Hypoxemia during one-lung ventilation results primarily from shunt through the non-ventilated lung. Applying CPAP (typically 5-10 cmH2O) to the non-ventilated lung provides oxygen to the collapsed lung and recruits some alveoli, reducing shunt fraction while minimally interfering with surgical exposure. Increasing PEEP on the ventilated lung may overdistend already hyperinflated COPD lung and divert blood flow to the non-ventilated lung, worsening shunt. Increasing tidal volume risks barotrauma. Inhaled nitric oxide to the ventilated lung improves V/Q matching but is less effective than addressing the shunt directly. Pulmonary artery clamping is invasive and typically reserved for pneumonectomy.", "generator_model": "claude-opus-4-5-20251101", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Anesthesiology", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: V. Verdict: Correct best answer. The stem describes severe hypoxemia (SpO2 84%, PaO2 52 mmHg) during one-lung ventilation in a COPD patient undergoing lobectomy. Key discriminating findings: confirmed correct tube position, adequate ventilation parameters (TV 350 mL, RR 14, PEEP 5), elevated peak pressure (38 cmH2O suggesting poor compliance), and severe hypoxemia despite FiO2 1.0. The primary mechanism is intrapulmonary shunt through the non-ventilated operative lung. Option A (CPAP to operative lung) directly addresses shunt by recruiting collapsed alveoli and providing oxygen while minimally interfering with surgery—this is the standard first-line intervention. Option B risks overdistending the already compromised COPD lung and worsening V/Q mismatch by diverting blood to the non-ventilated side. Option C (increased TV) risks barotrauma given already elevated peak pressures. Option D (inhaled NO) improves V/Q matching in ventilated areas but doesn't address the primary shunt problem as effectively. Option E is invasive and reserved for pneumonectomy, not lobectomy. The item is logically valid with clear stem support for a unique best answer. Medical accuracy is excellent, reflecting current anesthesia practice for one-lung ventilation management. No fix needed.\", \"medical_accuracy_score\": \"5\", \"logical_validity\": true, \"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best answer. The stem describes severe hypoxemia (SpO2 84%, PaO2 52 mmHg) during one-lung ventilation in a COPD patient undergoing lobectomy. Key discriminating findings: confirmed correct tube position, adequate ventilation parameters (TV 350 mL, RR 14, PEEP 5), elevated peak pressure (38 cmH2O suggesting poor compliance), and severe hypoxemia despite FiO2 1.0. The primary mechanism is intrapulmonary shunt through the non-ventilated operative lung. Option A (CPAP to operative lung) directly addresses shunt by recruiting collapsed alveoli and providing oxygen while minimally interfering with surgery—this is the standard first-line intervention. Option B risks overdistending the already compromised COPD lung and worsening V/Q mismatch by diverting blood to the non-ventilated side. Option C (increased TV) risks barotrauma given already elevated peak pressures. Option D (inhaled NO) improves V/Q matching in ventilated areas but doesn't address the primary shunt problem as effectively. Option E is invasive and reserved for pneumonectomy, not lobectomy. The item is logically valid with clear stem support for a unique best answer. Medical accuracy is excellent, reflecting current anesthesia practice for one-lung ventilation management. No fix needed.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128-015", "question": "A 35-year-old woman with no psychiatric history presents with acute onset of bizarre behavior, visual hallucinations, and seizures over 3 days. She has no fever. MRI brain shows bilateral medial temporal lobe T2 hyperintensities. CSF analysis reveals lymphocytic pleocytosis (45 cells/μL), elevated protein (68 mg/dL), and normal glucose. EEG shows extreme delta brush pattern. Anti-NMDA receptor antibodies return positive in CSF. CT of chest, abdomen, and pelvis reveals a 4-cm right ovarian mass. After tumor resection (pathology confirms ovarian teratoma), she receives first-line immunotherapy with high-dose corticosteroids, IVIG, and plasmapheresis. At week 6, she remains comatose with persistent seizures. Which of the following is the most appropriate next step in management?", "options": ["Continue current immunotherapy regimen for additional 6 weeks", "Initiate rituximab 375 mg/m² weekly for 4 doses", "Initiate cyclophosphamide 750 mg/m² monthly", "Initiate rituximab and cyclophosphamide combination therapy", "Initiate intrathecal methotrexate"], "answer": "D", "answer_index": 3, "explanation": "Anti-NMDA receptor encephalitis refractory to first-line therapy (tumor removal, corticosteroids, IVIG, and/or plasmapheresis) requires escalation to second-line immunotherapy. Current evidence and expert consensus support combination rituximab and cyclophosphamide as second-line therapy for refractory cases, as this combination targets both B-cell mediated antibody production and provides broader immunosuppression. Using either agent alone is less effective in severe refractory cases. Continuing first-line therapy alone when there is no response at 6 weeks delays effective treatment. Intrathecal methotrexate is not standard therapy for autoimmune encephalitis.", "generator_model": "claude-opus-4-5-20251101", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: V. Verdict: Correct best answer. The vignette describes classic anti-NMDA receptor encephalitis with pathognomonic features: young woman, psychiatric symptoms, seizures, extreme delta brush on EEG, positive anti-NMDA antibodies, and ovarian teratoma. Key discriminating findings: (1) tumor resected, (2) first-line immunotherapy completed (steroids, IVIG, plasmapheresis), (3) week 6 with persistent coma and seizures indicating treatment failure. The question asks for next management step in refractory disease. Option D (rituximab + cyclophosphamide combination) is the established second-line therapy for refractory anti-NMDA encephalitis per current literature and expert consensus. Option A is incorrect—continuing failed first-line therapy for 6 more weeks delays effective treatment. Options B and C (monotherapy with either agent) are suboptimal; combination therapy is superior in severe refractory cases. Option E (intrathecal methotrexate) is not standard for autoimmune encephalitis. The stem provides sufficient detail to identify treatment failure and need for escalation. Medical accuracy is excellent—reflects current standard of care for this specific autoimmune encephalitis. No logical flaws or ambiguity. Minimal fix: None needed; item is well-constructed and discriminates appropriately between first-line continuation, monotherapy escalation, and combination second-line therapy.\", \"medical_accuracy_score\": \"5\", \"logical_validity\": true, \"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best answer. The vignette describes classic anti-NMDA receptor encephalitis with pathognomonic features: young woman, psychiatric symptoms, seizures, extreme delta brush on EEG, positive anti-NMDA antibodies, and ovarian teratoma. Key discriminating findings: (1) tumor resected, (2) first-line immunotherapy completed (steroids, IVIG, plasmapheresis), (3) week 6 with persistent coma and seizures indicating treatment failure. The question asks for next management step in refractory disease. Option D (rituximab + cyclophosphamide combination) is the established second-line therapy for refractory anti-NMDA encephalitis per current literature and expert consensus. Option A is incorrect—continuing failed first-line therapy for 6 more weeks delays effective treatment. Options B and C (monotherapy with either agent) are suboptimal; combination therapy is superior in severe refractory cases. Option E (intrathecal methotrexate) is not standard for autoimmune encephalitis. The stem provides sufficient detail to identify treatment failure and need for escalation. Medical accuracy is excellent—reflects current standard of care for this specific autoimmune encephalitis. No logical flaws or ambiguity. Minimal fix: None needed; item is well-constructed and discriminates appropriately between first-line continuation, monotherapy escalation, and combination second-line therapy.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128-016", "question": "A 72-year-old man with major depressive disorder has failed adequate trials of sertraline, venlafaxine, and mirtazapine augmented with aripiprazole. He has no psychotic features. Medical history includes coronary artery disease with drug-eluting stent placed 8 months ago (on aspirin and clopidogrel), hypertension, and benign prostatic hyperplasia. He is referred for electroconvulsive therapy (ECT). Pre-ECT cardiac evaluation shows EF 55% with no active ischemia. Which of the following medication adjustments is most appropriate before initiating ECT?", "options": ["Discontinue clopidogrel 7 days before first ECT session", "Hold aspirin on the morning of each ECT session", "Continue dual antiplatelet therapy without modification", "Bridge with enoxaparin after stopping clopidogrel", "Switch clopidogrel to ticagrelor for shorter half-life"], "answer": "C", "answer_index": 2, "explanation": "Current evidence and guidelines support continuing dual antiplatelet therapy (DAPT) during ECT. The risk of stent thrombosis from discontinuing antiplatelet therapy within 12 months of drug-eluting stent placement significantly outweighs the minimal bleeding risk associated with ECT. ECT does not involve surgical incisions, and intracranial hemorrhage during ECT is exceedingly rare even on anticoagulation. Discontinuing or bridging antiplatelet therapy is not recommended. The transient hypertension during ECT seizure is manageable with appropriate anesthetic technique and does not contraindicate the procedure in stable coronary disease.", "generator_model": "claude-opus-4-5-20251101", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V. Verdict: Correct best answer. The stem presents a 72-year-old with treatment-resistant depression requiring ECT who has a drug-eluting stent placed 8 months ago on dual antiplatelet therapy (DAPT). Key discriminating findings: (1) stent placed <12 months ago, (2) on aspirin+clopidogrel, (3) stable cardiac status (EF 55%, no active ischemia), (4) ECT is non-invasive. The clinical question asks for appropriate medication management before ECT. Choice C (continue DAPT) is correct because: ECT is non-invasive with no surgical incisions; premature discontinuation of DAPT within 12 months of drug-eluting stent carries high stent thrombosis risk (potentially fatal); intracranial hemorrhage during ECT is exceedingly rare even on anticoagulation; current guidelines support continuing antiplatelet therapy during ECT. Alternative analysis: A/D/E create unacceptable stent thrombosis risk by interrupting clopidogrel within the critical 12-month window; B (holding aspirin) is unnecessary and still increases thrombotic risk; bridging with enoxaparin (D) is inappropriate as DAPT doesn't require bridging for non-invasive procedures. Medical accuracy: fully consistent with AHA/ACC stent guidelines and ECT safety literature. No logical flaws or missing details. Minimal fix: none needed; item is valid as written.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best answer. The stem presents a 72-year-old with treatment-resistant depression requiring ECT who has a drug-eluting stent placed 8 months ago on dual antiplatelet therapy (DAPT). Key discriminating findings: (1) stent placed <12 months ago, (2) on aspirin+clopidogrel, (3) stable cardiac status (EF 55%, no active ischemia), (4) ECT is non-invasive. The clinical question asks for appropriate medication management before ECT. Choice C (continue DAPT) is correct because: ECT is non-invasive with no surgical incisions; premature discontinuation of DAPT within 12 months of drug-eluting stent carries high stent thrombosis risk (potentially fatal); intracranial hemorrhage during ECT is exceedingly rare even on anticoagulation; current guidelines support continuing antiplatelet therapy during ECT. Alternative analysis: A/D/E create unacceptable stent thrombosis risk by interrupting clopidogrel within the critical 12-month window; B (holding aspirin) is unnecessary and still increases thrombotic risk; bridging with enoxaparin (D) is inappropriate as DAPT doesn't require bridging for non-invasive procedures. Medical accuracy: fully consistent with AHA/ACC stent guidelines and ECT safety literature. No logical flaws or missing details. Minimal fix: none needed; item is valid as written.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128-017", "question": "A 19-year-old college student is brought to the emergency department by campus police after being found in her dormitory room with superficial lacerations on both forearms. She reports cutting herself \"to feel something\" after her boyfriend ended their 2-month relationship. She denies suicidal ideation and states she \"would never actually kill herself.\" She describes a pattern of intense, unstable relationships, chronic feelings of emptiness, and impulsive behaviors including binge eating and reckless driving. She has had multiple similar presentations over the past 3 years. Mental status examination reveals dramatic affect with rapid shifts between tearfulness and anger. Which of the following is the most appropriate disposition?", "options": ["Involuntary psychiatric hospitalization for imminent self-harm risk", "Voluntary psychiatric hospitalization for stabilization", "Discharge with outpatient dialectical behavior therapy referral", "Discharge with outpatient psychodynamic psychotherapy referral", "23-hour observation unit placement with crisis intervention"], "answer": "C", "answer_index": 2, "explanation": "This patient presents with borderline personality disorder (BPD) with non-suicidal self-injury (NSSI). Evidence strongly supports that psychiatric hospitalization for NSSI in BPD is generally not beneficial and may be harmful by reinforcing maladaptive behaviors and disrupting outpatient treatment. Dialectical behavior therapy (DBT) is the most evidence-based treatment for BPD and specifically targets self-harm behaviors. The patient denies suicidal intent, has a pattern consistent with NSSI rather than suicide attempts, and does not meet criteria for involuntary commitment. Outpatient DBT referral with appropriate safety planning is the standard of care.", "generator_model": "claude-opus-4-5-20251101", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: M (Multiple answers defensible). Verdict: Not uniquely determinable. The vignette describes a 19-year-old with borderline personality disorder features and non-suicidal self-injury (NSSI) presenting to the ED with superficial lacerations. Key stem clues: denies suicidal ideation, states \\\"would never actually kill herself,\\\" pattern of NSSI, chronic BPD symptoms. The question asks for \\\"most appropriate disposition.\\\" While the rationale correctly notes DBT is evidence-based for BPD and hospitalization may reinforce maladaptive behaviors, immediate discharge (C) versus brief observation with crisis intervention (E) are both defensible. Option E provides a middle ground: brief stabilization, safety assessment, crisis intervention, and outpatient referral planning—standard ED practice for self-harm presentations. Option C's immediate discharge without any observation period is clinically aggressive for an acute self-harm presentation, even with NSSI. The stem lacks critical details: severity of current distress, adequacy of outpatient support, immediate safety plan feasibility, availability of DBT. Medical accuracy issue: While long-term hospitalization is contraindicated in BPD/NSSI, brief ED observation is standard practice and not harmful. The item conflates extended hospitalization with any observation period. Minimal fix: Specify \\\"patient is calm, has supportive roommate present, and DBT intake available within 48 hours\\\" to make immediate discharge (C) uniquely best, or clarify that observation unit is unavailable.\", \"medical_accuracy_score\": \"3\", \"logical_validity\": false, \"logical_false_reason\": \"M\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: M (Multiple answers defensible). Verdict: Not uniquely determinable. The vignette describes a 19-year-old with borderline personality disorder features and non-suicidal self-injury (NSSI) presenting to the ED with superficial lacerations. Key stem clues: denies suicidal ideation, states \"would never actually kill herself,\" pattern of NSSI, chronic BPD symptoms. The question asks for \"most appropriate disposition.\" While the rationale correctly notes DBT is evidence-based for BPD and hospitalization may reinforce maladaptive behaviors, immediate discharge (C) versus brief observation with crisis intervention (E) are both defensible. Option E provides a middle ground: brief stabilization, safety assessment, crisis intervention, and outpatient referral planning—standard ED practice for self-harm presentations. Option C's immediate discharge without any observation period is clinically aggressive for an acute self-harm presentation, even with NSSI. The stem lacks critical details: severity of current distress, adequacy of outpatient support, immediate safety plan feasibility, availability of DBT. Medical accuracy issue: While long-term hospitalization is contraindicated in BPD/NSSI, brief ED observation is standard practice and not harmful. The item conflates extended hospitalization with any observation period. Minimal fix: Specify \"patient is calm, has supportive roommate present, and DBT intake available within 48 hours\" to make immediate discharge (C) uniquely best, or clarify that observation unit is unavailable.", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "M", "verdict": "FAIL", "fail_reason": "M"}, "judge_verdict": "FAIL", "judge_fail_reason": "M", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128-018", "question": "A 48-year-old woman undergoes total thyroidectomy for papillary thyroid carcinoma. The surgeon identifies and preserves both recurrent laryngeal nerves using intraoperative nerve monitoring. Twelve hours postoperatively, she develops progressive dyspnea, stridor, and neck swelling. Oxygen saturation is 88% on room air. The surgical site shows tense swelling with ecchymosis. Bedside flexible laryngoscopy reveals bilateral vocal cord immobility in the paramedian position with adequate glottic airway. Which of the following is the most appropriate immediate management?", "options": ["Emergent wound exploration and hematoma evacuation at bedside", "Emergent return to operating room for wound exploration", "Emergent awake tracheostomy under local anesthesia", "Emergent cricothyroidotomy", "Endotracheal intubation followed by wound exploration"], "answer": "A", "answer_index": 0, "explanation": "Post-thyroidectomy hematoma with airway compromise is a surgical emergency requiring immediate wound exploration and hematoma evacuation. When the patient has stridor and respiratory distress from neck hematoma, opening the wound at bedside (even in the absence of full surgical setup) is the fastest way to decompress the airway. This can be performed by opening skin staples/sutures and evacuating clot, which immediately relieves tracheal compression. Waiting for OR availability or attempting intubation in a patient with distorted anatomy and bilateral vocal cord paralysis risks complete airway loss. Tracheostomy and cricothyroidotomy are more invasive and time-consuming than simple wound opening.", "generator_model": "claude-opus-4-5-20251101", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "General Surgery", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: K (Miskeyed). Verdict: Miskeyed - option E is the correct best answer, not A. Key stem clues: 12-hour post-thyroidectomy with progressive dyspnea, stridor, 88% O2 saturation, tense neck swelling with ecchymosis indicating expanding hematoma. Critical finding: laryngoscopy shows bilateral vocal cord immobility in paramedian position WITH adequate glottic airway. Main logical issue: The stem explicitly states \\\"adequate glottic airway\\\" on laryngoscopy, which contradicts the rationale's assumption of tracheal compression requiring emergent bedside evacuation. With adequate glottic airway visualized, the primary threat is expanding hematoma causing external tracheal compression, not glottic obstruction. Standard management is securing the airway first (intubation) before definitive treatment. Bedside wound exploration (option A) without airway control in a hypoxic patient (88% saturation) with bilateral cord immobility risks catastrophic airway loss if bleeding worsens or anatomy shifts during manipulation. Option E (intubation followed by exploration) is the standard approach: secure airway first, then address hematoma under controlled conditions. Medical accuracy issue: The rationale incorrectly prioritizes bedside evacuation over airway security when adequate glottic opening exists. Minimal fix: Remove \\\"adequate glottic airway\\\" from laryngoscopy findings OR change key to E.\", \"medical_accuracy_score\": \"3\", \"logical_validity\": false, \"logical_false_reason\": \"K\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed). Verdict: Miskeyed - option E is the correct best answer, not A. Key stem clues: 12-hour post-thyroidectomy with progressive dyspnea, stridor, 88% O2 saturation, tense neck swelling with ecchymosis indicating expanding hematoma. Critical finding: laryngoscopy shows bilateral vocal cord immobility in paramedian position WITH adequate glottic airway. Main logical issue: The stem explicitly states \"adequate glottic airway\" on laryngoscopy, which contradicts the rationale's assumption of tracheal compression requiring emergent bedside evacuation. With adequate glottic airway visualized, the primary threat is expanding hematoma causing external tracheal compression, not glottic obstruction. Standard management is securing the airway first (intubation) before definitive treatment. Bedside wound exploration (option A) without airway control in a hypoxic patient (88% saturation) with bilateral cord immobility risks catastrophic airway loss if bleeding worsens or anatomy shifts during manipulation. Option E (intubation followed by exploration) is the standard approach: secure airway first, then address hematoma under controlled conditions. Medical accuracy issue: The rationale incorrectly prioritizes bedside evacuation over airway security when adequate glottic opening exists. Minimal fix: Remove \"adequate glottic airway\" from laryngoscopy findings OR change key to E.", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128-019", "question": "A 55-year-old man with cirrhosis secondary to hepatitis C (Child-Pugh class B, MELD score 18) presents with a 3-cm hepatocellular carcinoma in segment VI, discovered on surveillance imaging. He has no extrahepatic disease and no macrovascular invasion. Portal vein is patent. He has moderate ascites controlled with diuretics and no history of hepatic encephalopathy. Performance status is ECOG 0. The hepatology tumor board discusses treatment options. According to the Barcelona Clinic Liver Cancer (BCLC) staging system, which of the following is the most appropriate treatment recommendation?", "options": ["Liver transplantation", "Surgical resection", "Radiofrequency ablation", "Transarterial chemoembolization", "Sorafenib"], "answer": "A", "answer_index": 0, "explanation": "This patient has BCLC stage A (early HCC) with a single tumor ≤3 cm, but with Child-Pugh B cirrhosis and portal hypertension (evidenced by ascites). According to BCLC guidelines, surgical resection is only recommended for patients with preserved liver function (Child-Pugh A) without portal hypertension. For patients with early HCC and impaired liver function, liver transplantation is the preferred treatment as it addresses both the tumor and underlying liver disease. This patient meets Milan criteria (single tumor ≤5 cm). Ablation is an alternative for non-transplant candidates. TACE is for intermediate stage, and sorafenib for advanced stage disease.", "generator_model": "claude-opus-4-5-20251101", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "General Surgery", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: M (Multiple answers defensible). Verdict: Not uniquely determinable. The stem describes a 55-year-old with Child-Pugh B cirrhosis, MELD 18, ECOG 0, single 3-cm HCC in segment VI, moderate ascites on diuretics, no encephalopathy, meeting Milan criteria. Key discriminating findings: Child-Pugh B, portal hypertension (ascites), single tumor ≤3 cm, ECOG 0, no contraindications to transplant mentioned. The rationale correctly identifies BCLC stage A and notes transplant addresses both tumor and cirrhosis. However, the item is underspecified regarding transplant candidacy and availability. In real practice, liver transplantation (A) requires donor availability, waitlist considerations, and formal candidacy evaluation—factors not addressed. Radiofrequency ablation (C) is explicitly recommended by BCLC for early HCC when resection/transplant are not feasible, and for a peripheral 3-cm lesion in segment VI, ablation is technically feasible and guideline-supported. Both A and C are defensible: transplant is ideal if available/candidate appropriate; ablation is standard if transplant unavailable or as bridge therapy. The stem does not specify transplant availability or candidacy status beyond meeting Milan criteria. Main logical issue: U→M (underspecified transplant feasibility leading to multiple defensible answers). Minimal fix: Add 'The patient is an acceptable transplant candidate with expected waitlist time of 6 months' to make transplant unambiguously best, or specify 'not a transplant candidate' to make ablation best.\", \"medical_accuracy_score\": \"4\", \"logical_validity\": false, \"logical_false_reason\": \"M\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: M (Multiple answers defensible). Verdict: Not uniquely determinable. The stem describes a 55-year-old with Child-Pugh B cirrhosis, MELD 18, ECOG 0, single 3-cm HCC in segment VI, moderate ascites on diuretics, no encephalopathy, meeting Milan criteria. Key discriminating findings: Child-Pugh B, portal hypertension (ascites), single tumor ≤3 cm, ECOG 0, no contraindications to transplant mentioned. The rationale correctly identifies BCLC stage A and notes transplant addresses both tumor and cirrhosis. However, the item is underspecified regarding transplant candidacy and availability. In real practice, liver transplantation (A) requires donor availability, waitlist considerations, and formal candidacy evaluation—factors not addressed. Radiofrequency ablation (C) is explicitly recommended by BCLC for early HCC when resection/transplant are not feasible, and for a peripheral 3-cm lesion in segment VI, ablation is technically feasible and guideline-supported. Both A and C are defensible: transplant is ideal if available/candidate appropriate; ablation is standard if transplant unavailable or as bridge therapy. The stem does not specify transplant availability or candidacy status beyond meeting Milan criteria. Main logical issue: U→M (underspecified transplant feasibility leading to multiple defensible answers). Minimal fix: Add 'The patient is an acceptable transplant candidate with expected waitlist time of 6 months' to make transplant unambiguously best, or specify 'not a transplant candidate' to make ablation best.", "medical_accuracy_score": 4, "logical_validity": false, "logical_false_reason": "M", "verdict": "FAIL", "fail_reason": "M"}, "judge_verdict": "FAIL", "judge_fail_reason": "M", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128-020", "question": "A 62-year-old woman with type 2 diabetes presents with a 2-day history of severe right eye pain, redness, and decreased vision. She reports seeing halos around lights. Visual acuity is counting fingers at 2 feet OD and 20/30 OS. Examination reveals conjunctival injection, corneal edema with microcystic changes, a mid-dilated non-reactive pupil, and shallow anterior chamber OD. Intraocular pressure is 58 mmHg OD and 16 mmHg OS. Gonioscopy of the left eye shows narrow angles with appositional closure in the superior quadrant. After initial medical therapy with topical timolol, brimonidine, pilocarpine, and intravenous acetazolamide, IOP decreases to 32 mmHg at 2 hours. Corneal edema persists. Which of the following is the most appropriate definitive treatment?", "options": ["Laser peripheral iridotomy of the right eye only", "Laser peripheral iridotomy of both eyes", "Trabeculectomy of the right eye", "Phacoemulsification with intraocular lens implantation of the right eye", "Argon laser trabeculoplasty of the right eye"], "answer": "B", "answer_index": 1, "explanation": "This patient has acute primary angle-closure glaucoma (APACG). Laser peripheral iridotomy (LPI) is the definitive treatment as it creates an alternative pathway for aqueous flow, relieving pupillary block. Critically, LPI must be performed on BOTH eyes because angle-closure is a bilateral anatomical predisposition-the fellow eye has a 40-80% risk of developing acute angle closure if left untreated, as evidenced by the narrow angles with appositional closure seen on gonioscopy OS. Trabeculectomy is reserved for cases with persistent IOP elevation after LPI. Phacoemulsification may be considered later but is not first-line. Argon laser trabeculoplasty is contraindicated in angle closure.", "generator_model": "claude-opus-4-5-20251101", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Ophthalmology", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: V. Verdict: Correct best answer. The vignette describes classic acute primary angle-closure glaucoma (APACG) in the right eye: severe pain, decreased vision, halos, mid-dilated non-reactive pupil, corneal edema, shallow anterior chamber, and markedly elevated IOP (58 mmHg). The critical discriminating finding is gonioscopy of the fellow eye showing narrow angles with appositional closure, establishing bilateral anatomical predisposition. After partial IOP response to medical therapy, laser peripheral iridotomy (LPI) is the definitive treatment to relieve pupillary block. The key question is whether to treat one or both eyes. Option B (bilateral LPI) is correct because the fellow eye has 40-80% risk of acute angle closure given the documented narrow angles with appositional closure. This is standard practice supported by all major guidelines. Option A treats only the affected eye, leaving the fellow eye at high risk. Options C, D, and E are inappropriate: trabeculectomy is reserved for LPI failures, phacoemulsification is not first-line definitive treatment, and argon laser trabeculoplasty is contraindicated in angle closure. The stem provides sufficient detail to identify a unique best answer. No medical inaccuracies detected. Minimal fix: None needed; item is valid and accurate.\", \"medical_accuracy_score\": \"5\", \"logical_validity\": true, \"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best answer. The vignette describes classic acute primary angle-closure glaucoma (APACG) in the right eye: severe pain, decreased vision, halos, mid-dilated non-reactive pupil, corneal edema, shallow anterior chamber, and markedly elevated IOP (58 mmHg). The critical discriminating finding is gonioscopy of the fellow eye showing narrow angles with appositional closure, establishing bilateral anatomical predisposition. After partial IOP response to medical therapy, laser peripheral iridotomy (LPI) is the definitive treatment to relieve pupillary block. The key question is whether to treat one or both eyes. Option B (bilateral LPI) is correct because the fellow eye has 40-80% risk of acute angle closure given the documented narrow angles with appositional closure. This is standard practice supported by all major guidelines. Option A treats only the affected eye, leaving the fellow eye at high risk. Options C, D, and E are inappropriate: trabeculectomy is reserved for LPI failures, phacoemulsification is not first-line definitive treatment, and argon laser trabeculoplasty is contraindicated in angle closure. The stem provides sufficient detail to identify a unique best answer. No medical inaccuracies detected. Minimal fix: None needed; item is valid and accurate.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}]